The University of Connecticut has reappointed Dr. Bruce T. Liang as dean of its UConn School of Medicine in Farmington, effective July 1.
This is Liang’s third, five-year term, having served as dean since 2015. He is also a cardiovascular physician-scientist at the Pat and Jim Calhoun Cardiology Center of UConn Health.
Anne D’Alleva, UConn provost and executive vice president for academic affairs, said Liang’s reappointment “reflects the strong foundation he has built and the significant progress achieved over the past decade.”
During his previous five-year term, Liang oversaw implementation of the M Delta curriculum, which focuses more on team-based learning and less on lecture-style coursework.
The school also expanded its class size, exceeding targets set by Bioscience Connecticut, a state investment launched in 2011 to position Connecticut as a leader in biomedical research and innovation.
Liang also led the development of a Science Strategy Plan aligned with UConn’s priorities, recruited faculty and helped drive an increase in funding from the National Institutes of Health (NIH). Under his leadership, the medical school has received record-breaking annual research grant funding of over $100 million.
During his previous term as dean, Liang also served as interim CEO of UConn Health for more than two years, guiding the institution through a leadership transition.
In addition to serving as dean of the UConn School of Medicine, Liang is the Ray Neag Distinguished Professor of Cardiovascular Biology and Medicine. Before joining the UConn Health faculty in 2002, he served 13 years at the University of Pennsylvania School of Medicine as associate professor of medicine and pharmacology.
